Role of Iron and B-Catenin Activation in Gastric Carcinogenesis

铁和 B-连环蛋白激活在胃癌发生中的作用

基本信息

项目摘要

H. pylori is the strongest known risk factor for gastric adenocarcinoma, the second leading cause of cancer-related death worldwide, yet only a fraction of infected persons ever develop this malignancy. One H. pylori determinant that augments cancer risk is the cag type IV secretion system (T4SS), which translocates the microbial oncoprotein GagA into epithelial cells. Our preliminary data generated with Project 2 demonstrate that intracellular delivery of GagA activates B-catenin and that a consequence of Beta catenin activation within H. pylori-infected epithelial cells is hyperproliferation. Our studies have also demonstrated that iron depletion augments the ability of H. pylori to activate Beta-catenin. We have now shown with Gastric Histopathology Core A that iron depletion accelerates the development of H. pylori induced cancer in gerbils in a cagA-dependent manner. Two-dimensional (20) DIGE/mass spectrometry performed by Proteomics Core B identified 33 differentially abundant proteins among H. pylori strains isolated from iron-depleted versus iron-replete gerbils, several of which mediate microbial adherence and function of the cag T4SS. These results directly informed provocative new studies performed with Project 3 demonstrating that H. pylori strains harvested from iron-depleted gerbils or grown under iron-depleted conditions in vitro exhibit an enhanced capacity to assemble the cag T4SS, translocate GagA, and induce expression of proinflammatory cytokines. We have also developed new models of H. pylori infection that more closely recapitulate events occurring within the gastric niche. Gastric organoids are three dimensional, single-layered epithelial organ-like structures, and provide a unique opportunity to study host H. pylori interactions in a pre-clinical model. We have now successfully grown, maintained, characterized, and infected gastric organoids with H. pylori. Our hypothesis is that iron depletion augments H. pylori cag� dependent oncogenesis. We will test this via the following Aims: 1. Define mechanisms that regulate oncogenesis in response to iron deprivation and H. pylori. 2. Define H. pylori-induced carcinogenic responses using a novel ex vivo organoid system. 3. Define differences in epithelial molecular responses to carcinogenic H. pylori versus a cagA- mutant strain using a gerbil model of gastric cancer within the context of iron depletion.
H.幽门螺杆菌是胃腺癌的最强已知危险因素,胃腺癌是全世界癌症相关死亡的第二大原因,然而只有一小部分感染者发展成这种恶性肿瘤。一个H增加癌症风险的幽门螺杆菌决定因子是cag IV型分泌系统(T4 SS),其将微生物癌蛋白GagA易位到上皮细胞中。我们的项目2产生的初步数据表明,细胞内GagA的传递激活B-连环蛋白,并且在H.幽门感染的上皮细胞过度增殖。我们的研究还表明,铁缺乏增强了H。pylori以激活β-连环蛋白。我们现在已经用胃组织学核心A表明铁缺乏加速了H的发展。pylori以cagA依赖的方式诱导沙鼠的癌症。蛋白质组学核心B进行的二维(20)DIGE/质谱鉴定了H.幽门螺杆菌菌株分离自铁缺乏与铁充满沙鼠,其中几个介导微生物粘附和功能的cag T4 SS。这些结果直接通知挑衅性的新研究与项目3表明,H。从铁缺乏的沙鼠收获的或在铁缺乏的条件下体外生长的幽门螺杆菌菌株表现出增强的组装cag T4 SS、易位GagA和诱导促炎细胞因子表达的能力。我们还开发了H.幽门螺杆菌感染,更密切地重演发生在胃龛内的事件。胃类器官是三维的单层上皮样器官结构,为研究宿主H。幽门螺杆菌的相互作用在临床前模型。我们现在已经成功地培养,维持,表征和感染了H。幽门。我们的假设是铁的缺乏增加了H。pylori cag依赖性肿瘤发生。我们将通过以下目标进行测试: 1.定义响应铁剥夺和H调节肿瘤发生的机制。幽门。 2.定义H幽门诱导的致癌反应,使用一种新的离体类器官系统。 3.定义上皮细胞对致癌性H的分子反应的差异。幽门螺杆菌与cagA突变株使用沙土鼠胃癌模型的背景下,铁耗竭。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD M. PEEK其他文献

RICHARD M. PEEK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD M. PEEK', 18)}}的其他基金

H. Pylori Relationship to Digestive Diseases and Cancer
幽门螺杆菌与消化系统疾病和癌症的关系
  • 批准号:
    10846242
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
Mechanisms that Regulate Helicobacter pylori-Induced beta-catenin Activation
调节幽门螺杆菌诱导的 β-连环蛋白激活的机制
  • 批准号:
    8413057
  • 财政年份:
    2013
  • 资助金额:
    $ 28.23万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8413062
  • 财政年份:
    2013
  • 资助金额:
    $ 28.23万
  • 项目类别:
H. Pylori-Induced Inflammation and Gastric Cancer
幽门螺杆菌引起的炎症和胃癌
  • 批准号:
    8011208
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:
H. Pylori-Induced Inflammation and Gastric Cancer
幽门螺杆菌引起的炎症和胃癌
  • 批准号:
    7753610
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9274166
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:
H. pylori-Induced Inflammation and gastric cancer
幽门螺杆菌引起的炎症和胃癌
  • 批准号:
    9203563
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8632359
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:
H. pylori-Induced Inflammation and gastric cancer
幽门螺杆菌引起的炎症和胃癌
  • 批准号:
    8821584
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:
H. Pylori-Induced Inflammation and Gastric Cancer
幽门螺杆菌引起的炎症和胃癌
  • 批准号:
    8212343
  • 财政年份:
    2009
  • 资助金额:
    $ 28.23万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 28.23万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了